Rossby Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$268K Sell
11,140
-1,749
-14% -$45.8K 0.05% 326
2026
Q1
$368K Sell
12,889
-860
-6% -$22.9K 0.08% 238
2025
Q4
$342K Buy
13,749
+215
+2% +$5.42K 0.11% 169
2025
Q3
$368K Buy
13,534
+1,801
+15% +$44.5K 0.12% 167
2025
Q2
$284K Buy
11,733
+2,411
+26% +$56.2K 0.11% 193
2025
Q1
$214K Buy
9,322
+538
+6% +$14.1K 0.09% 217
2024
Q4
$233K Buy
+8,784
New +$238K 0.14% 160

Other funds holding PFE

Rossby Financial's PFE Position: Q2 2026 in Review

Rossby Financial reduced its Pfizer (PFE) stake by 14% in Q2 2026, selling an estimated $45.8K and leaving 11,140 shares worth $268K. The position accounts for 0.05% of the portfolio, ranked #326.

Rossby Financial first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $368K in Q3 2025. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Rossby Financial held 11,140 shares of Pfizer worth $268K as of Q2 2026.
  • Rossby Financial sold 1,749 Pfizer shares in Q2 2026, an estimated $45.8K.
  • Pfizer made up 0.05% of Rossby Financial's portfolio in Q2 2026, its #326 holding.
  • Rossby Financial first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Rossby Financial's Pfizer position peaked at $368K in Q3 2025.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.